![Revaccinatie tegen hepatitis B bij non-responders. Resultaten van een retrospectieve studie en opzet van een prospectief onderzoek (RESPONS) / IB 03-2013 | RIVM Revaccinatie tegen hepatitis B bij non-responders. Resultaten van een retrospectieve studie en opzet van een prospectief onderzoek (RESPONS) / IB 03-2013 | RIVM](https://www.rivm.nl/sites/default/files/2018-11/005060_IB24_03_Art_Revacc_Figuur1.jpg)
Revaccinatie tegen hepatitis B bij non-responders. Resultaten van een retrospectieve studie en opzet van een prospectief onderzoek (RESPONS) / IB 03-2013 | RIVM
![Long-term assessment of the immunological response to hepatitis B vaccines in 136 haemodialysis patients | Nefrología Long-term assessment of the immunological response to hepatitis B vaccines in 136 haemodialysis patients | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251409003680:41118078_t1_pag417.jpg?idApp=UINPBA000064)
Long-term assessment of the immunological response to hepatitis B vaccines in 136 haemodialysis patients | Nefrología
![Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20160921001220283-0073:S0950268813001064:S0950268813001064_tab1.gif?pub-status=live)
Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core
![Hoe goed beschermt jouw vaccin tegen de varianten van het coronavirus? Ontdek het hier | VRT NWS: nieuws Hoe goed beschermt jouw vaccin tegen de varianten van het coronavirus? Ontdek het hier | VRT NWS: nieuws](https://interactief.vrtnws.be/2021/img/vaccins/pf.png)
Hoe goed beschermt jouw vaccin tegen de varianten van het coronavirus? Ontdek het hier | VRT NWS: nieuws
PLOS ONE: Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination
![Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20160921001220283-0073:S0950268813001064:S0950268813001064_fig1g.jpeg?pub-status=live)
Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core
![Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20160921001220283-0073:S0950268813001064:S0950268813001064_fig2g.gif?pub-status=live)
Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation | Epidemiology & Infection | Cambridge Core
![SciELO - Saúde Pública - Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Primary and booster vaccination with SciELO - Saúde Pública - Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Primary and booster vaccination with](https://www.scielosp.org/media/assets/rpsp/v12n4/12885t2.gif)
SciELO - Saúde Pública - Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Primary and booster vaccination with
![Poor Adherence Contributes to Inadequate Uptake of Multidose Hepatitis Vaccine Schedules - Clinical Advisor Poor Adherence Contributes to Inadequate Uptake of Multidose Hepatitis Vaccine Schedules - Clinical Advisor](https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/hepatitisbvaccinesh364252355_1450943.jpg)
Poor Adherence Contributes to Inadequate Uptake of Multidose Hepatitis Vaccine Schedules - Clinical Advisor
![Hoe goed beschermt jouw vaccin tegen de varianten van het coronavirus? Ontdek het hier | VRT NWS: nieuws Hoe goed beschermt jouw vaccin tegen de varianten van het coronavirus? Ontdek het hier | VRT NWS: nieuws](https://interactief.vrtnws.be/2021/img/vaccins/jj.png)